<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">

On Demand Webinar

Synergistic Insights with Patient-Derived Models & Multi-Omics for Translational Oncology

Watch our webinar that delves into the innovative integration of patient-derived model systems with multi-omic solutions to revolutionize translational oncology drug discovery. This webinar is designed for professionals aiming to enhance their understanding and application of cutting-edge techniques in their research and development workflows.

In this webinar, you'll learn more about:

  • Integration of Patient-Derived Model Systems: Learn how to incorporate in vivo PDX, in vitro organoids, and ex vivo patient tissue into your drug discovery processes.

  • Leveraging Multi-Omics and Bioinformatics: Discover how multi-omics approaches and advanced bioinformatics can reveal therapeutic efficacy, identify responsive patient populations, and pinpoint potential biomarkers.

  • Optimal Models for Immuno-Oncology: Gain insights into selecting and utilizing the best models for immuno-oncology (IO) drug evaluation, understanding when and how to deploy them effectively.

About The Presenter:


Rajendra Kumari, PhD, Executive Director, Integrated Solutions, Crown Bioscience

As Executive Director of Integrated Solutions within the Commercial and Strategic Development team, Rajendra leads the focus of cross-disciplinary solutions for drug discovery and development. She has over 20 years of oncology research experience with a Ph.D. in Molecular Pharmacology from the University of Leicester (UK). Prior to joining Crown Bioscience, Rajendra held post-doctoral fellowships and an Assistant Professor position in the Division of Preclinical Oncology within the Medical School, University of Nottingham, where she developed in vitro and in vivo preclinical models, including patient-derived systems and imaging capabilities. Rajendra also co-founded PRECOS Ltd. in 2010, serving as COO and then following the merger with Crown Bioscience, as CSO and General Manager for Crown Bioscience UK. In 2018, Rajendra became the Global Head of Scientific Communications for all platforms at Crown Bioscience Inc., working closely with multiple divisions and global departments to support the commercialization of R&D activity and capabilities. Rajendra is a member of the AACR and BACR and has authored over 40 abstracts and publications.

Watch Now

Your privacy is important to us.
We'll never share your information.